As of July 2026, 35 paid clinical trials are recruiting for Blood cancer in Hackensack, New Jersey. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Hackensack has approximately 301 recruiting research studies across a wide range of therapeutic areas. New Jersey hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Researchers run research studies in Hackensack, NJ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Hackensack University Medical Center | Heart Failure, Advanced Solid Tumor, Acute Myeloid Leukemia | 123 |
| John Theurer Cancer Center at Hackensack University Medical Center | Acute Myeloid Leukemia, Leukemia, Myeloid, Acute, Breast Cancer | 41 |
| John Theurer Cancer Center | Melanoma, Urothelial Carcinoma, Advanced Non-Small Cell Lung Cancer | 12 |
| Hackensack Meridian Health | Atrial Fibrillation, Breast Cancer, Cardiogenic Shock | 10 |
| John Theurer Cancer Center at Hackensack UMC | Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Lung Cancer | 7 |
| John Theurer Cancer Center Hackensack University Medical Center | Advanced Solid Tumor, Advanced Solid Tumors, Chronic Lymphocytic Leukemia | 6 |
| Northeast Regional Epilepsy Group | Focal Onset Seizures, KCNT1-Related Epilepsy, Lennox Gastaut Syndrome | 5 |
| Hackensack Meridian Health - Hackensack University Medical Center | Crohn's Disease, Ulcerative Colitis, Plasma Cell Myeloma Refractory | 5 |
| Hackensack Meridian Health (Data collection only) | Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma, High Grade B Cell Lymphoma | 4 |
| Hackensack Medical Center | Acute Myeloid Leukemia, Alzheimer Disease, Chronic Myelomonocytic Leukemia | 3 |
| Praxis Research Site | Developmental and Epileptic Encephalopathy 1, Focal Onset Seizure, Focal Seizure | 3 |
| HMH Hackensack University Medical Center | Clostridioides Difficile Associated Disease, Stroke, Acute | 2 |
| Hackensack Univeristy Medical Center | Pre-Term, Premature, Respiratory Distress Syndrome in Premature Infant | 2 |
| Hackensack University Medical Center - John Theurer Cancer Center | Endometrial Cancer, Non-squamous EGFR Wt NSCLC, Ovarian Cancer | 2 |
| John Theurer Cancer Center-Hackensack | Locally Advanced Extrapulmonary Neuroendocrine Carcinoma, Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung, Locally Advanced Merkel Cell Carcinoma | 2 |
| Joseph M. Sanzari Children's Hospital | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 2 |
| NEREG | Focal Epilepsy | 2 |
| Investigative | Solid Tumors, Hidradenitis Suppurativa (HS) | 2 |
| Amanda Khoudary | Lung Cancer | 1 |
| Ascentage Investigative | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL | 1 |
| Context Investigational Site | Cholangiocarcinoma Advanced, Cholangiocarcinoma Non-resectable, Colorectal Cancer | 1 |
| Exelixis Clinical | Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC) | 1 |
| GSK Investigational Site | Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 1 |
| HMH David Jurist Research Building | Clostridioides Difficile Associated Disease | 1 |
| HMH Hospitals Corporation | AV Block, Heart Failure, Heart Failure With Reduced Ejection Fraction | 1 |
Recruiting trials in Hackensack grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in New Jersey are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Jersey research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Hackensack from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 301 recruiting clinical trials in Hackensack, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Hackensack compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Hackensack include Acute Myeloid Leukemia (10), Breast Cancer (9), Advanced Solid Tumor (8), Heart Failure (8), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hackensack on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Hackensack include Hackensack University Medical Center, John Theurer Cancer Center at Hackensack University Medical Center, John Theurer Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Hackensack are Cancer & tumors (164), Cardiovascular (14), Neurology & pain (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.